Evidence map›Paper›PMID 28545070›Full record

ArticlePloS one2017

POU4F3 mutation screening in Japanese hearing loss patients: Massively parallel DNA sequencing-based analysis identified novel variants associated with autosomal dominant hearing loss.

Tomohiro Kitano, Maiko Miyagawa, Shin-Ya Nishio, Hideaki Moteki, Kiyoshi Oda, Kenji Ohyama, Hiromitsu Miyazaki, Hiroshi Hidaka, Ken-Ichi Nakamura, Takaaki Murata and 11 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.6field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 45 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Gene-Polymorphism in Non - Syndromic Hearing Loss: A Systematic Review.Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India · 2025
    Article
  6. The transcription factorFrontiers in cellular neuroscience · 2024
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Cochlear implantation in a patient with aClinical case reports · 2021
    Article
  17. A MissenseBioMed research international · 2021
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 11 institutions in 1 country.

Tomohiro KitanoDepartment of Otorhinolaryngology, Shinshu University School of Medicine, Matsumoto, Japan.
Maiko MiyagawaDepartment of Otorhinolaryngology, Shinshu University School of Medicine, Matsumoto, Japan.
Shin-Ya NishioDepartment of Otorhinolaryngology, Shinshu University School of Medicine, Matsumoto, Japan.
Hideaki MotekiDepartment of Otorhinolaryngology, Shinshu University School of Medicine, Matsumoto, Japan.
Kiyoshi OdaDepartment of Otorhinolaryngology, Tohoku Rosai Hospital, Sendai, Japan.
Kenji OhyamaDepartment of Otorhinolaryngology, Tohoku Rosai Hospital, Sendai, Japan.
Hiromitsu MiyazakiDepartment of Otorhinolaryngology-Head and Neck Surgery, Tohoku University School of Medicine, Sendai, Japan.
Hiroshi HidakaDepartment of Otorhinolaryngology-Head and Neck Surgery, Tohoku University School of Medicine, Sendai, Japan.
Ken-Ichi NakamuraDepartment of Otolaryngology-Head and Neck Surgery, Jichi Medical University School of Medicine, Shimotsuke, Japan.
Takaaki MurataDepartment of Otolaryngology-Head and Neck Surgery, Gunma University Graduate School of Medicine, Maebashi, Japan.
Rina MatsuokaDepartment of Otorhinolaryngology, Juntendo University Faculty of Medicine, Tokyo, Japan.
Yoko OhtaDepartment of Otorhinolaryngology Head and Neck Surgery, Tokyo Medical University, Tokyo, Japan.
Nobuhiro NishiyamaDepartment of Otorhinolaryngology Head and Neck Surgery, Tokyo Medical University, Tokyo, Japan.
Kozo KumakawaDepartment of Otorhinolaryngology, Toranomon Hospital, Tokyo, Japan.
Sakiko FurutateDepartment of Otorhinolaryngology, International University of Health and Welfare, Mita Hospital, Tokyo, Japan.
Satoshi IwasakiDepartment of Otorhinolaryngology, International University of Health and Welfare, Mita Hospital, Tokyo, Japan.
Takechiyo YamadaDepartment of Otorhinolaryngology-Head and Neck Surgery, University of Fukui, Fukui, Japan.
Yumi OhtaDepartment of Otorhinolaryngology-Head and Neck Surgery, Osaka University Graduate School of Medicine, Osaka, Japan.
Natsumi UeharaDepartment of Otolaryngology-Head and Neck Surgery, Kobe University School of Medicine, Kobe, Japan.
Yoshihiro NoguchiDepartment of Hearing Implant Sciences, Shinshu University School of Medicine, Matsumoto, Japan.
Shin-Ichi UsamiDepartment of Otorhinolaryngology, Shinshu University School of Medicine, Matsumoto, Japan.ORCID http://orcid.org/0000-0002-5068-6122
Shinshu University · JPTokyo Medical University · JPMita Hospital · JPTohoku Rosai Hospital · JPTohoku University · JPGunma University · JPJichi Medical University · JPJuntendo University · JPKobe University · JPToranomon Hospital · JPUniversity of Fukui · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A variant in a transcription factor gene, POU4F3, is responsible for autosomal dominant nonsyndromic hereditary hearing loss, DFNA15. To date, 14 variants, including a whole deletion of POU4F3, have been reported to cause HL in various ethnic groups. In the present study, genetic screening for POU4F3 variants was carried out for a large series of Japanese hearing loss (HL) patients to clarify the prevalence and clinical characteristics of DFNA15 in the Japanese population. Massively parallel DNA sequencing of 68 target candidate genes was utilized in 2,549 unrelated Japanese HL patients (probands) to identify genomic variations responsible for HL. The detailed clinical features in patients with POU4F3 variants were collected from medical charts and analyzed. Novel 12 POU4F3 likely pathogenic variants (six missense variants, three frameshift variants, and three nonsense variants) were successfully identified in 15 probands (2.5%) among 602 families exhibiting autosomal dominant HL, whereas no variants were detected in the other 1,947 probands with autosomal recessive or inheritance pattern unknown HL. To obtain the audiovestibular configuration of the patients harboring POU4F3 variants, we collected audiograms and vestibular symptoms of the probands and their affected family members. Audiovestibular phenotypes in a total of 24 individuals from the 15 families possessing variants were characterized by progressive HL, with a large variation in the onset age and severity with or without vestibular symptoms observed. Pure-tone audiograms indicated the most prevalent configuration as mid-frequency HL type followed by high-frequency HL type, with asymmetry observed in approximately 20% of affected individuals. Analysis of the relationship between age and pure-tone average suggested that individuals with truncating variants showed earlier onset and slower progression of HL than did those with non-truncating variants. The present study showed that variants in POU4F3 were a common cause of autosomal dominant HL.

Indexed as

AdolescentAdultAgedAsian PeopleChildChild, PreschoolCodon, NonsenseDNAFemaleFrameshift MutationGene FrequencyHearing Loss, SensorineuralHigh-Throughput Nucleotide SequencingHomeodomain ProteinsHumansInfantCodon, NonsenseDNAHomeodomain ProteinsPOU4F3 protein, humanTranscription Factor Brn-3C

Identifiers

PMID28545070
PMCPMC5435223
OpenAlexW2615704118

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.